NCT04680611View on ClinicalTrials.gov

Severe Asthma, MepolizumaB and Affect: SAMBA Study

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

September 9, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Severe Eosinophilic AsthmaPsychological DistressAnxietyDepressionPsychological StressPsychological AdjustmentPsychological DisorderPsychosocial ProblemPsychosocial StressorPsychologicalEmotionsEmotional DisorderEmotional DysfunctionEmotional DistressAdjustmentAdjustment, EmotionalCoping Behavior
Interventions
OTHER

no study intervention. Patients receive standard clinical care

no intervention. observational study

Trial Locations (6)

AB25 2ZN

RECRUITING

Department of Respiratory Medicine, Aberdeen Royal Infirmary, Aberdeen

SO166YD

RECRUITING

Judit Varkonyi-Sepp, Southampton

HU16 5JQ

RECRUITING

Hull University Teaching Hospitals NHS Trust, Hull

WF1 4DG

RECRUITING

Pinderfields Hospital, Wakefield

G12 0YN

RECRUITING

Glasgow Gartnavel General Hospital, Glasgow

Unknown

RECRUITING

Portsmouth Hospitals NHS Trust, Portsmouth

All Listed Sponsors
collaborator

Portsmouth Hospitals NHS Trust

OTHER_GOV

collaborator

University of Derby

OTHER

lead

University Hospital Southampton NHS Foundation Trust

OTHER